(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol

ID: ALA397705

Chembl Id: CHEMBL397705

Cas Number: 39188-58-4

PubChem CID: 9669

Max Phase: Preclinical

Molecular Formula: C19H27NO

Molecular Weight: 285.43

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: (-)-Pentazocine | Rel-Pentazocine | Rel-Pentazocine|CHEMBL397705|(-)-PENTAZOCINE|NSC107430|SCHEMBL135685|39188-58-4|BDBM50001033|BDBM50407300|PDSP2_001111|Pentazocine, Pentazocin, Sosegon, WIN 20228

Canonical SMILES:  CC(C)=CCN1CC[C@@]2(C)c3cc(O)ccc3C[C@@H]1[C@H]2C

Standard InChI:  InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3/t14-,18-,19-/m1/s1

Standard InChI Key:  VOKSWYLNZZRQPF-NIKGAXFTSA-N

Alternative Forms

  1. Parent:

Associated Targets(Human)

SIGMAR1 Tclin Sigma opioid receptor (6358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Sigmar1 Sigma opioid receptor (1607 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oprm1 Mu opioid receptor (6060 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SIGMAR1 Sigma-1 receptor (3326 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NET Transporter (332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a4 Serotonin transporter (6087 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Slc6a3 Dopamine transporter (6071 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Mu opioid receptor (3620 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Kappa opioid receptor (4577 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Opioid receptor (mu and kappa) (192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 285.43Molecular Weight (Monoisotopic): 285.2093AlogP: 3.88#Rotatable Bonds: 2
Polar Surface Area: 23.47Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.42CX Basic pKa: 9.57CX LogP: 3.89CX LogD: 1.99
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.83Np Likeness Score: 1.75

References

1. Glennon RA, Ablordeppey SY, Ismaiel AM, el-Ashmawy MB, Fischer JB, Howie KB..  (1994)  Structural features important for sigma 1 receptor binding.,  37  (8): [PMID:8164264] [10.1021/jm00034a020]
2. Hori M, Ban M, Imai E, Iwata N, Suzuki Y, Baba Y, Morita T, Fujimura H, Nozaki M, Niwa M..  (1985)  Novel nonnarcotic analgesics with an improved therapeutic ratio. Structure-activity relationships of 8-(methylthio)- and 8-(acylthio)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines.,  28  (11): [PMID:2999399] [10.1021/jm00149a020]
3. Oshiro Y, Sakurai Y, Sato S, Kurahashi N, Tanaka T, Kikuchi T, Tottori K, Uwahodo Y, Miwa T, Nishi T..  (2000)  3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.,  43  (2): [PMID:10649973] [10.1021/jm980333v]
4. Perregaard J, Moltzen EK, Meier E, Sánchez C..  (1995)  Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles.,  38  (11): [PMID:7783131] [10.1021/jm00011a019]
5. Moltzen EK, Perregaard J, Meier E..  (1995)  Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines.,  38  (11): [PMID:7783132] [10.1021/jm00011a020]
6. Yoshida F, Topliss JG..  (2000)  QSAR model for drug human oral bioavailability.,  43  (13): [PMID:10891117] [10.1021/jm0000564]
7. Carroll FI, Abraham P, Parham K, Bai X, Zhang X, Brine GA, Mascarella SW, Martin BR, May EL, Sauss C..  (1992)  Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors.,  35  (15): [PMID:1322987] [10.1021/jm00093a014]
8. Danso-Danquah R, Bai X, Zhang X, Mascarella SW, Williams W, Sine B, Bowen WD, Carroll FI..  (1995)  Synthesis and sigma binding properties of 2'-substituted 5,9 alpha-dimethyl-6,7-benzomorphans.,  38  (15): [PMID:7636860] [10.1021/jm00015a022]
9. Danso-Danquah R, Bai X, Zhang X, Mascarella SW, Williams W, Sine B, Bowen WD, Carroll FI..  (1995)  Synthesis and sigma binding properties of 1'- and 3'-halo- and 1',3'-dihalo-N-normetazocine analogues.,  38  (15): [PMID:7636861] [10.1021/jm00015a023]
10. Carroll FI, Bai X, Dehghani A, Mascarella SW, Williams W, Bowen WD..  (1999)  Asymmetric synthesis of 9-alkyl-2-benzyl-6,7-benzomorphans: characterization as novel sigma receptor ligands.,  42  (22): [PMID:10579824] [10.1021/jm990169r]
11. Leland DL, Kotick MP..  (1981)  Analgesic narcotic antagonists. 5. 7,7-Dimethyldihydrocodeinones and 7,7-dimethyldihydromorphinones.,  24  (6): [PMID:6166748] [10.1021/jm00138a015]
12. Wentland MP, Lou R, Lu Q, Bu Y, VanAlstine MA, Cohen DJ, Bidlack JM..  (2009)  Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.,  19  (1): [PMID:19027293] [10.1016/j.bmcl.2008.10.134]
13. Cao J, Kopajtic T, Katz JL, Newman AH..  (2008)  Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol.,  18  (19): [PMID:18774292] [10.1016/j.bmcl.2008.08.065]
14. Hsin LW, Chang LT, Rothman RB, Dersch CM, Fishback JA, Matsumoto RR..  (2010)  Synthesis and opioid activity of enantiomeric N-substituted 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolines.,  53  (3): [PMID:20055417] [10.1021/jm901503e]
15. Yamamoto N, Fujii H, Nemoto T, Nakajima R, Momen S, Izumimoto N, Hasebe K, Mochizuki H, Nagase H..  (2011)  Synthesis of new opioid derivatives with a propellane skeleton and their pharmacology: part 1.,  21  (13): [PMID:21641798] [10.1016/j.bmcl.2011.04.147]
16. Laurini E, Col VD, Mamolo MG, Zampieri D, Posocco P, Fermeglia M, Vio L, Pricl S..  (2011)  Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor.,  (11): [PMID:24900272] [10.1021/ml2001505]
17. Adhikari A, Kalluraya B, Sujith KV, Gouthamchandra K, Jairam R, Mahmood R, Sankolli R..  (2012)  Synthesis, characterization and pharmacological study of 4,5-dihydropyrazolines carrying pyrimidine moiety.,  55  [PMID:22877623] [10.1016/j.ejmech.2012.07.002]
18. Sujith KV, Kalluraya B, Adhikari A, Vijayanarayana K.  (2012)  Microwave-mediated synthesis of triazolothiadiazoles as anti-inflammatory, analgesic, and anti-oxidant agents,  21  (5): [10.1007/s00044-011-9569-5]
19. Nigade G, Chavan P, Deodhar M.  (2012)  Synthesis and analgesic activity of new pyridine-based heterocyclic derivatives,  21  (1): [10.1007/s00044-010-9489-9]
20. Albertson NF, Michne WF, Tullar BF..  (1978)  Benzomorphans. Structure of a position isomer.,  21  (5): [PMID:660593] [10.1021/jm00203a013]

Source